Hemodynamic disturbances in patients with infective endocarditis (IE) 
Infective endocarditis (IE) is still a serious disease with a high mortality (16 -20%) overall. It is a localized infection involving the heart valves in the majority of patients, but it is also often a generalized infection associated with the systemic inflammatory response syndrome and numerous septic metastases in various parts of the body. Due to this, there is a diversity of pathogenic mechanisms involved in the hemodynamic changes in IE. The clinical and microbiological spectra of IE have been evolving continually from the first descriptions of the disease at the beginning of the 20th century. The changing profile of IE is nowadays well established and documented (table 1) . (1) (2) (3) During the first seventy years of the twentieth century IE was usually of a subacute clinical course because less pathogenic bacteria, like alpha-hemolytic streptococci of the viridans group, dominated as major pathogens. They did not induce a pronounced inflammatory response. Rheumatic valve disease was the major underlying cause. Nowadays, the course of IE is mostly acute, septic and the most common pathogen is Staphylococcus aureus. The incidence of enterococcal or Streptococcus bovis infections has risen. Atherosclerotic valvular disease is the most common form of valvular disease due to the increased incidence of degenerative valvular lesions associated with an ageing population. IE occurs in patients without previously known cardiac disease in up to almost 50% of patients. The average age of patients with IE has increased over time resulting in a shift towards the eighth or even ninth decade of life. Other more prevalent risk factors associated with IE, are patients with implanted intracardiac devices (pacemakers, defibrillators) although, fortunately, there is a decreased incidence in patients with prosthetic valve infective endocarditis (PVIE). A horrific increase in the number of intravenous drug addicts has led to a greater incidence of right-sided IE. Recently, some other epidemiological characteristics of IE have emerged. Although community-acquired infections still dominate, health care associated infections are growing, particularly those associated with dialysis, implantation of Hickman's and Broviac catheters and other invasive procedures. (4) All these changes affect the hemodynamics in patients with IE in regard to its pathogenesis and incidence (figure 1). While hemodynamic derangements associated with valvular or paravalvular dysfunctions are well known, changes associated with systemic inflammatory response syndrome (SIRS) and organ dysfunctions are not adequately addressed in clinical research of IE. It is often forgotten that IE is only one segment of a generalized, acute systemic inflammatory response -sepsis. The most established hemodynamic changes are associated with infections of valves and surrounding tissues and consequent valve dysfunction. The most important and most severe complication is congestive heart failure (CHF) which may rapidly progress due to the dysfunction of heart valves (rapid progression of aortic and/or mitral regurgitation), valve perforation, formation of a paravalvular abscess and fistulation, paravalvular leak due to dehiscence of prosthetic valves (table 2) . Congestive heart failure demands earlier surgical intervention, which is one of the most important factors today contributing to a better prognosis. CHF, along with embolizations, is the most common complication of IE. The incidence of CHF in patients with IE is 30% to 40%. Despite this, CHF has not been particularly evaluated in separate studies because it is a well-known complication with few unresolved questions. Our center in the Hospital for Infectious Diseases is actively involved in a project known as the 'International Collaboration on Endocarditis Prospective Surveillance'. A global database has been formed which includes over 5000 patients from all continents. The center of the project is at Duke University. I will present here an analysis of the incidence and characteristics of patients with CHF. There have been, up until now, 2787 patients with definite IE according to Duke criteria. The mean age is 56+-18 years; males dominate (68%). CHF occurred in 877 (32%) of patients. The severity of CHF was reported in 761 patients (193 missing values) according to NYHA classification (figure 2). These data suggest that CHF is a severe, life threatening complication in the majority of patients in whom it occurred. However, it is not easy to interpret these data because often patients with IE are septic and symptoms of sepsis overlap symptoms and signs of CHF. Does CHF occur more often in elderly patients? Despite a slight tendency towards a greater incidence in the group of patients older than 74 years, the difference was not statistically significant ( figure 3 ). This is in accordance with other ICE reports. One might expect that because of a worse prognosis for patients with PVIE, the incidence of CHF is higher compared to native valve disease. We were not able to confirm this. The incidence of CHF was 621 out of 1906 (32.6%) patients with NVIE and 175 out of 564 (31%) patients with PVIE. Is localization of IE associated with CHF? Sexton and al. showed that aortic valve disease is more commonly associated with CHF than mitral valve involvement (28% vs. 20%). (5) In our group of patients with left-sided NVIE the incidence of CHF was significantly higher if both valves were affected (53.7%) than if only the aortic valve (37.5%) or mitral valve (31.1%) were involved. Since S. aureus is the most common pathogen causing IE today with a worse prognosis than IE caused by other bacteria, we asked if S. aureus IE was associated with a greater incidence of CHF. Interestingly, there was a significant increase in the incidence of CHF among patients with staphylococcal NVIE (34.1% vs. 29.4%, p=0.04). That was not observed in PVIE (figure 4). There was no difference in the incidence of CHF in patients with IE caused with MSSA compared to MRSA. Patients with CHF were more commonly subjected to cardiac surgery than patients without CHF (62% vs. 38.9%, p<0.001 in NVIE and 55.1% vs. 45.4%, Changes associated with sepsis
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